Challenges and impact of rare diseases are faced by pharmacy stakeholders.
Gordon J. Vanscoy, PharmD, MBA
Advertisement
Articles by Gordon J. Vanscoy, PharmD, MBA
The rarity of disease states coupled with novel medication mechanisms and high costs lead to complexities in accessing treatment and optimizing outcomes.
Advertisement
Latest Updated Articles
Rare Pharmacy Emerges From Specialty: Part 1Published: July 30th 2020 | Updated:
Rare Pharmacy Emerges From Specialty, Part 2Published: August 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
2
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
3
Pharmacy Policy Updates for October 2025
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
